Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| -10.6% | -10% | -10% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| -10.6% | -10% | -10% |
The Canopy Global Small & Mid Cap Fund declined 0.6% in April, underperforming its benchmark by 4.1%. The fund maintains a concentrated 32-stock portfolio focused on high-quality small and mid-cap companies with competitive advantages. Key contributors included SBAC, which surged 29% on private market acquisition rumors, leading to position trimming, and Wise. Major detractors were Badger Meter, which fell 21% after disappointing Q1 results due to project timing gaps and soft routine orders, though the managers added to the position citing intact structural tailwinds. The broader market rebounded 4% as the TACO rally accelerated, driven by strong AI-related earnings and risk appetite despite geopolitical tensions and oil above $100. Information Technology led with 20% gains on AI capex momentum. The fund's quality metrics significantly outperform benchmarks with 29% EBIT margins versus 9% for the index, 42% return on capital versus 9%, and lower leverage at 0.6x versus 2.0x.
The fund invests in a concentrated portfolio of high quality and attractively priced small and mid-cap companies with demonstrable competitive advantages, aligned management, strong financial results, and favorable ESG characteristics across balanced sector and regional exposures.
Management expects the awarded project pipeline to support a 2027 recovery for water infrastructure investments, while central bank responses to energy-driven inflation are likely to remain the key focus into Q2.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 23 2026 | 2026 Q1 | BMI, SBAC | global, infrastructure, Quality, small caps, technology, Telecom Infrastructure, water |
SBAC BMI |
Canopy's concentrated small-cap fund declined 0.6% in April, trimming SBAC on acquisition rumors while adding to Badger Meter after earnings disappointment. The portfolio maintains superior quality metrics with 29% EBIT margins and 42% return on capital versus benchmark. Strong AI earnings drove broader market recovery despite geopolitical tensions and elevated oil prices. |
| Jan 15 2026 | 2025 Q4 | 4194.T, ASSA-B.ST, AUTO.L, AZEK, JHX, MEDP, MONC.MI, NEM, PTC, TREX, TW | AI, Enterprise Software, global, Japan, Quality, SMID Cap, valuation |
PTC MEDP AUTO LN TREX 4194 JP |
Canopy's global SMID fund fell 9.2% as markets rotated from quality to speculative stocks amid AI enthusiasm. Portfolio companies grew earnings 9% but suffered broad PE de-rating with 25 of 32 stocks compressed. Fund believes AI disruption fears overdone for high-quality holdings now trading at attractive valuations near 10-year lows. |
| Oct 28 2025 | 2025 Q3 | AZO, BVI.PA, EDEN.PA, HEI, MCO.PA, MEDP, ROL, SBAC, STE, SXS.L, TREX, TW | AI, Biotechnology, Construction, Defensive, global, Quality, semiconductors, small caps |
MEDP US TREX US MEDP US TREX US MEDP TREX |
Canopy's global small-mid cap fund fell 4.4% in September as markets favored speculation over quality. Biotech exposure via Medpace contributed positively while construction-related Trex declined on macro headwinds. The manager sees concerning speculative market dynamics but maintains conviction in quality companies positioned for long-term growth over the five to seven year investment horizon. |
| Jul 15 2025 | 2025 Q2 | DOL.TO, EDEN.PA, HEI, ICON, MEDP, TW, WISE.L | global, Quality, small caps, Speculation, Trump, underperformance, value |
WISE HEI 4194 JP ICLR DOL CN EDEN FP HEI 4390.T WISE.L ICLR DOL.TO EDEN.PA |
Canopy's global small-mid cap fund returned 9.4% net in FY25 but underperformed due to speculative market surge in areas they avoid. Strong fundamentals from quality holdings like Dollarama offset healthcare headwinds from Icon. Fund maintains strict quality discipline with 30 companies expected to grow earnings 13% annually, positioning for long-term outperformance despite elevated market uncertainty. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIStrong Q1 earnings across the AI supply chain reinforced risk appetite and drove Information Technology sector gains of 20%. Stocks leveraged to AI capex performed particularly well during the month. |
AI Technology Capex |
WaterBadger Meter supplies water meters and smart monitoring technology but faced disappointing Q1 results due to an air gap between project cohorts and unexpected softness in routine replacement orders. Management maintains multi-year growth framework with structural tailwinds from smart metering adoption intact. |
Water Smart Metering Infrastructure | |
Telecom InfrastructureSBAC leases mobile phone towers with revenue backed by long-term, inflation-linked contracts and growth linked to mobile data growth. Earnings have been negatively impacted by customer consolidation and higher interest rates, though private market valuations exceed public market valuations. |
Towers Infrastructure Telecom | |
| 2025 Q4 |
Shareholder ActivismShareholder activism reached all-time highs in 2025 with 152 campaigns in North America, up 20.6% from 2024. The strategy has evolved from stigmatized to necessity as passive investing increases and more non-activist managers resort to activism to realize intrinsic value. |
Activism Campaigns Proxy Governance Value |
SemiconductorsEbara Corporation represents a semiconductor capital equipment opportunity, forming a duopoly in chemical mechanical planarization with Applied Materials. AI semiconductors demand greater CMP intensity, offering Ebara enhanced growth runway and market share gains. |
CMP Equipment AI Wafers Manufacturing | |
NuclearKEPCO is Japan's top nuclear power operator with 6,580 MW capacity, deriving 48% of electrical output from nuclear. The company benefits from favorable nuclear mix and limited Fukushima impact, making it Japan's most profitable electric utility. |
Nuclear Power Utilities Japan KEPCO | |
Medical DevicesInteger Holdings is the largest medical device CDMO specializing in cardiovascular and neuromodulation applications with high barriers to change due to regulatory requirements. Despite strong market position, the company faces near-term growth challenges. |
CDMO Cardiovascular Neuromodulation FDA Manufacturing | |
EntertainmentSix Flags Entertainment operates 27 amusement parks across North America but faces operational execution issues, technology integration problems, and balance sheet challenges following the Cedar Fair merger. Multiple activists see value creation opportunities. |
Amusement Parks Technology Integration Operations | |
| 2025 Q3 |
BiotechnologySmall biotechs are the engine of innovation in the pharma industry and are expected to grow at high-single-digit rates over the medium term. Biotech funding levels and Pfizer's agreement with the Trump Administration on drug pricing have been cautiously positive developments. |
CRO Pharma Innovation Funding Drug Pricing |
AIGlobal equities rallied in September owing to renewed enthusiasm around AI following successive deal announcements by OpenAI and Nvidia. This benefited semiconductor-related companies and firms perceived to be AI beneficiaries. |
OpenAI Nvidia Semiconductors Deal Announcements | |
| 2025 Q2 |
QualityThe Fund maintains strict quality and valuation discipline, investing in high-quality companies with strong competitive advantages. Quality companies are able to weather risk and emerge stronger during market downturns. |
Quality Profitability Competitive Advantages Resilience Discipline |
Dollar StoresDollarama operates the largest dollar store chain in Canada with remarkable consistency, delivering 11% annual revenue growth over 15 years without a single down year. The company appeals to a broad demographic and benefits from value-conscious consumers during economic weakness. |
Dollar Stores Retail Value Consumer Canada | |
CRO & CDMOIcon, a top-tier global clinical research organisation, faced significant challenges with a 25% reduction in consensus 2027 EPS estimates and 50% stock price decline. The market views reduced pharma R&D spending as either permanent or sees no immediate growth catalysts. |
CRO Clinical Research Pharmaceuticals R&D Biotech | |
PaymentsWise is the largest non-bank FX transfer service globally with founder-led dedication to lowering cross-border transaction fees. The company aims to replace aging financial plumbing that banks use for currency transfers, a market multiples the size of the consumer market. |
Payments FX Cross-border FinTech Banking |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Fund Letters | Canopy Investors | SBAC | SBA Communications | REIT - Specialty | Wireless Telecommunication Services | Neutral | NASDAQ | Brazil, Cell Towers, infrastructure, private equity, REITs, takeover target, telecommunications, US | Login |
| Apr 23, 2026 | Fund Letters | Canopy Investors | BMI | Badger Meter | Scientific & Technical Instruments | Electronic Equipment, Instruments & Components | Bull | New York Stock Exchange | growth, Industrials, infrastructure, Smart Technology, turnaround, US, utilities, Water Meters | Login |
| Jan 15, 2026 | Fund Letters | Jack McManus | TREX | Trex Company, Inc. | Industrials | Building Products | Bear | New York Stock Exchange | Building Products, Competition, Cyclicality, Housing, Margins | Login |
| Jan 15, 2026 | Fund Letters | Jack McManus | PTC | PTC Inc. | Information Technology | Application Software | Bull | NASDAQ | AI, Incumbency, Plm, Software, switching costs | Login |
| Jan 15, 2026 | Fund Letters | Jack McManus | MEDP | Medpace Holdings, Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Biotech, Bookings, Cro, Cyclicality, earnings | Login |
| Jan 15, 2026 | Fund Letters | Jack McManus | 4194 JP | Visional, Inc. | Industrials | Human Resource & Employment Services | Bull | New York Stock Exchange | Japan, Labor, Platforms, Recruitment, valuation | Login |
| Jan 15, 2026 | Fund Letters | Jack McManus | AUTO LN | Auto Trader Group plc | Communication Services | Interactive Media & Services | Bull | New York Stock Exchange | AI, Classifieds, Marketplaces, Pricing power, Sentiment | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | MEDP | Medpace Holdings Inc | Health Care | Biotechnology | Bull | NASDAQ | Biotech, Bookings, Cro, Margins, Outsourcing | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | MEDP US | Medpace Holdings, Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | — | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | TREX | Trex Company Inc | Industrials | Building Products | Bear | NYSE | construction, Decking, Housing, Macro, Remodeling, Sentiment | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | TREX US | Trex Company, Inc. | Industrials | Building Products | Bull | NYSE | — | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | MEDP US | Medpace Holdings, Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | — | Login |
| Oct 28, 2025 | Fund Letters | Jack McManus | TREX US | Trex Company, Inc. | Industrials | Building Products | Bull | NYSE | composite decking, housing cycle, Margins, market share, repair & remodel | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | WISE | Wise plc | Information Technology | Consumer Finance | Bull | NYSE | Fintech, growth, Payments, Platforms, Remittances | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | HEI | Heico Corp. | Industrials | Aerospace & Defense | Bull | NYSE | Aerospace, aftermarket, compounding, Defense, Margins | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | 4194 JP | Visional, Inc. | Communication Services | Interactive Media & Services | Bull | NYSE | Digitalization, Hiring, Labor, marketplace, Networks | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | ICLR | Icon plc | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | healthcare, Outsourcing, research, Trials, valuation | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | DOL CN | Dollarama Inc. | Other | Specialty Stores | Bull | TSX | consumer, discount, expansion, Margins, retail | Login |
| Jul 15, 2025 | Fund Letters | Jack McManus | EDEN FP | Edenred SE | Other | Consumer Finance | Bull | Euronext Stock Exchange | Benefits, growth, Networks, Payments, Regulation | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | EDEN.PA | Edenred SE | Financials | Financial Services | Bull | Euronext Paris | B2B payments, Employee Benefits, European Fintech, Meal Vouchers, network effects, Regulatory risk, tax efficiency | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | ICLR | Icon plc | Health Care | Life Sciences Tools & Services | Neutral | NASDAQ | Biotech Services, Clinical research, Cro, cyclical downturn, free cash flow yield, Pharma R&D, Value Investment | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | 4390.T | Visional Inc | Communication Services | Interactive Media & Services | Bull | Tokyo Stock Exchange | demographic trends, Hr Technology, Japan, Job Matching, Labor shortage, Mid-career Mobility, Professional Recruitment | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | WISE.L | Wise plc | Financials | Financial Services | Bull | London Stock Exchange | B2B Services, Banking Infrastructure, Cross Border Payments, Financial Plumbing, Fintech, founder-led, FX Transfer | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | DOL.TO | Dollarama Inc | Consumer Discretionary | Specialty Retail | Bull | Toronto Stock Exchange | Canadian Retail, discount retail, Dollar Store, international expansion, market dominance, operational efficiency, Private-label | Login |
| Jun 16, 2025 | Fund Letters | Canopy Investors | HEI | Heico Corporation | Industrials | Aerospace & Defense | Bull | NYSE | Aerospace, aftermarket, Aircraft Parts, Commercial Airlines, Defense, market share gains, OEM Alternative | Login |
| TICKER | COMMENTARY |
|---|---|
| SBAC | SBAC's share price increased 29% in April. SBAC leases mobile phone towers to wireless telcos primarily in the US and Brazil. Its revenue is backed by long-term, inflation-linked contracts, with growth linked to mobile data growth and spectrum releases. However, over the last year, its earnings have been negatively impacted by customer consolidation and higher interest rates as it refinanced low-yielding debt. While SBAC's Q1 result in April was fine, the share price increase during the month was driven by rumours that buyers were considering offers to take SBAC private. Valuations of tower assets in private markets have exceeded public market valuations for years, so this news is both unsurprising and unpredictable. We trimmed our exposure at the elevated price, understanding that acquisition rumours can disappear just as quickly as they surface. |
| BMI | Badger Meter, a major US supplier of water meters and smart monitoring technology, declined 21% in April after a disappointing Q1 result. The earnings miss reflected a previously flagged air gap as the 2023-25 cohort of large smart meter projects concluded ahead of the next awarded projects ramping up from H2, compounded by unexpected softness in routine replacement orders from smaller utilities. Management downgraded FY26 guidance but reaffirmed its multi-year high-single-digit growth framework, characterising the routine order weakness as timing-related, with the awarded project pipeline expected to support a 2027 recovery. We used the decline to modestly add to our position at what we view as an undemanding valuation, with Badger's quality and the structural tailwinds from smart metering adoption intact. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||